Furthermore, chromosomal abnormalities such as translocations forming oncogenic fusion proteins, i.e., AML1-ETO and MLL-AF9 in AML as well as ETV6-RUNX1 and TCF3-PBX1 in ALL, are frequently observed [49,50]. This evidence concerns the gene KMT2A and acute myeloid leukemia.